McKesson Corp. said late Monday it has agreed to buy RxCrossroads from CVS Health Corp. for $735 million. The deal will be funded by cash on hand, and it is expected to close in the fourth quarter, McKesson said in a statement. Following the close, RxCrossroads will become part of the company’s Specialty Health business. McKesson expects the transaction to add about 20 cents to adjusted per-share earnings by the third year after the deal is completed. Shares of McKesson were flat in late trading after ending the regular trading session down 1.7%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News